Correlation between increased serum sFas levels and microalbuminuria in type 1 diabetic patients

Medical Principles and Practice

Volumn 16, Issue 3, 2007, Pages 222-225

  Protopsaltis, John ^a   Kokkoris, Stelios ^a   Nikolopoulos, George ^a   Spyropoulou, Panagiota ^a   Katsaros, Thomas ^b   Salvanos, Leonardos ^a   Brestas, Paris ^a   Korantzopoulos, Panagiotis ^c   Melidonis, Andreas ^a  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

^c G HATZIKOSTA GENERAL HOSPITAL   (Greece)

Author keywords

Apoptosis; Diabetes; Diabetic nephropathy; Soluble Fas; Urinary albumin

Indexed keywords

ALBUMIN; CREATININE; FAS ANTIGEN; HEMOGLOBIN A1C; PROTEIN BCL 2;

ADULT; AGE DISTRIBUTION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROALBUMINURIA; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; URINE LEVEL;

ADULT; ALBUMINURIA; APOPTOSIS; CREATININE; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FEMALE; HEMOGLOBINS; HUMANS; MALE; STATISTICS, NONPARAMETRIC;

EID: 34147111736     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100394     Document Type: Article

References (18)

1. Anderson AR, Christiansen JS, Andersen JK, Kralner S, Dockert K: Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiologic study. Diabetologia 1985;25: 496-501.
2. Steffes MW, Osterby R, Chavers B, Mauer SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 1989; 38: 1077-1081.
3. Ortiz A, Lorz C, Justo P, Catalán MP, Egido J: Contribution of apoptotic cell death to renal injury. J Cell Mol Med 2001; 5: 18-32.
4. Zeiss CJ: The apoptosis-necrosis continuum: insights from genetically altered mice. Vet Pathol 2003; 40: 481-495.
5. Reed JC: Mechanisms of apoptosis. Am J Pathol 2000; 157: 1415-1430.
6. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J: Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental proliferative nephritis. J Clin Invest 1994; 94:2105-2116.
7. Poulsen PL, Mogensen CE: Clinical evaluation of a test for immediate and quantitative determination of urinary albumin to creatinine ratio. Diabetes Care 1998; 21: 97-98.
8. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogenesen CE, Parving HH, Steffes MW: Nephropathy in diabetes. Diabetes Care 2004; 27(suppl 1):S79-S83.
9. National Kidney Foundation: National Kidney Foundation Kidney Disease Outcomes Quality Initiative. 2006. http://www.kidney.org/professionals/kdoqi/ gfr_page.cfm.
10. Altman DG: Categorizing continuous variables; in Armitage P, Colton T (eds): Encyclopedia of Biostatistics. Chichester, Wiley, 1998, pp 563-567.
11. Ortiz A, Lorz C, Justo P, Catalan M, Egido J: Role and regulation of apoptotic cell death in the kidney. Front Biosci 2000;5:D735-D749.
12. Kikuchi Y, Nonoguchi H, Machida K, Wakamatsu S, Koga H, Tomita K: Regulation of the apoptosis-related genes, Bax and Bcl-2, in the early stage of diabetes mellitus. Nephrology 2002; 7: 294-302.
13. Haas CS, Schocklmann HO, Lang S, Kralewski M, Sterzel RB: Regulatory mechanism in glomerular mesangial cell proliferation. J Nephrol 1999; 12: 405-415.
14. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 1995; 47:114-121.
15. Perianayagam MC, Murray SL, Balakrishnan VS, Guo D, King AJ, Pereira BJ, Jaber BL: Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure. J Lab Clin Med 2000; 136: 320-327.
16. Onozaki A, Midorikawa S, Sanada H, Hayashi Y, Baba T, Katoh T, Watanabe T: Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione. Biochem Biophys Res Commun 2004; 317: 24-29.
17. Gerber HP, Dixit V, Ferrara N: Vascular endothelial growth factor induces expression of antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998;273: 1313-1316.
18. Nor JE, Christensen J, Mooney DJ, Polverini PJ: Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 1999; 154: 375-384.